Gene: SUMO4
Official Full Name: small ubiquitin like modifier 4provided by HGNC
Gene Summary: This gene is a member of the SUMO gene family. This family of genes encode small ubiquitin-related modifiers that are attached to proteins and control the target proteins' subcellular localization, stability, or activity. The protein described in this record is located in the cytoplasm and specifically modifies IKBA, leading to negative regulation of NF-kappa-B-dependent transcription of the IL12B gene. A specific polymorphism in this SUMO gene, which leads to the M55V substitution, has been associated with type I diabetes. The RefSeq contains this polymorphism. [provided by RefSeq, Jul 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA02726 | SUMO4 Knockout cell line (AC16) | Human | SUMO4 | 1:3-1:4 | negative | Online Inquiry |
| KOA18172 | SUMO4 Knockout cell line (BEAS-2B) | Human | SUMO4 | 1:3~1:4 | negative | Online Inquiry |
| KOA33622 | SUMO4 Knockout cell line (U-2932) | Human | SUMO4 | 1:2-1:4 | negative | Online Inquiry |
| KOA49028 | SUMO4 Knockout cell line (TPC-1) | Human | SUMO4 | 1:5-1:8 | negative | Online Inquiry |
| KOA64428 | SUMO4 Knockout cell line (NCM460) | Human | SUMO4 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.